Over the last 12 months, SOPHiA GENETICS insiders reported 1 buy totaling $99K and 28 sales totaling $2.2M across SEC Form 4 filings. 93% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 20,000 | $7.25 | $145K | -3.3% | plan · 3 tranches |
| Aug 4, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 5,000 | $6.95 | $35K | -2.6% | plan |
| Aug 4, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 20,000 | $6.92 | $138K | -0.6% | plan |
| Aug 4, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 10,000 | $6.92 | $69K | -1.6% | plan |
| Jul 27, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.66 | $28K | -2.2% | plan |
| Jul 21, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 44,381 | $6.45 | $286K | -1.3% | plan · 3 tranches |
| Jul 13, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.7 | $29K | -2.1% | plan |
| Jul 13, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $5.7 | $23K | -0.7% | plan |
| Jul 10, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 8,500 | $5.62 | $48K | -0.2% | plan |
| Jul 7, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 17,685 | $5.28 | $93K | -0.5% | plan |
| Jul 6, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▼ Sale | 1,592 | $5.29 | $8K | -0.5% | plan |
| Jul 6, 2026 | Valente ManuelaChief People Officer · O | ▼ Sale | 4,241 | $5.05 | $21K | -2% | plan |
| Jul 6, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 5,285 | $5.1 | $27K | -2.7% | plan |
| Jul 6, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 7,393 | $5.17 | $38K | -1.2% | plan |
| Jul 6, 2026 | Muken RossChief Executive Officer · O·D | ▼ Sale | 9,838 | $5.22 | $51K | -1.4% | plan |
| Jul 6, 2026 | Puylaert KevinChief Sales Officer · O | ▼ Sale | 216 | $5.03 | $1K | -0.1% | 3 tranches |
| Jul 6, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 7,393 | $5.16 | $38K | -3.1% | plan |
| Jul 6, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 22,486 | $5.26 | $118K | -0.6% | plan |
| Jun 30, 2026 | Camblong JurgiExecutive Chairman · O·D | ▼ Sale | 83,679 | $6.06 | $507K | -2.3% | plan · 5 tranches |
| Jun 26, 2026 | Camblong JurgiChief Executive Officer · O·D | ▼ Sale | 51,442 | $5.8 | $298K | -1.4% | plan · 3 tranches |
| Jun 25, 2026 | Verma AbhimanyuChief Technology Officer · O | ▼ Sale | 6,944 | $5.51 | $38K | -3.4% | plan |
| Jun 25, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $5.5 | $28K | -2% | plan |
| Jun 22, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▼ Sale | 774 | $5.38 | $4K | -0.2% | plan |
| Jun 22, 2026 | Muken RossPresident · O | ▼ Sale | 422 | $5.38 | $2K | -0.1% | plan |
| Jun 15, 2026 | Xu ZhenyuChief Scientific Officer · O | ▼ Sale | 4,000 | $5.01 | $20K | -0.6% | plan |
| Jun 12, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $4.95 | $25K | -2% | plan |
| Jun 10, 2026 | Camblong JurgiChief Executive Officer · O·D | ▼ Sale | 8,500 | $5.24 | $45K | -0.2% | plan |
| Jun 5, 2026 | CARDOZA GEORGEChief Financial Officer · O | ▲ Buy | 20,000 | $4.95 | $99K | +6.9% | — |
| May 26, 2026 | Menu PhilippeChief Medical Officer · O | ▼ Sale | 5,000 | $4.95 | $25K | -2% | plan · late |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SOPH feed.